Page last updated: 2024-12-05
2-chloro-1,1-difluoroethylene
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2-chloro-1,1-difluoroethylene: volatile metabolite of halothane [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 9664 |
MeSH ID | M0070062 |
Synonyms (33)
Synonym |
---|
ethene, 2-chloro-1,1-difluoro- |
ethylene, 2-chloro-1,1-difluoro- |
f 1122 |
1,1-difluorochloroethylene |
2-chloro-1,1-difluoroethylene |
brn 1736774 |
einecs 206-625-7 |
hcfc 1122 |
fc 1122 |
r 1122 |
2-chloro-1,1-difluoroethene |
359-10-4 |
A823037 |
AKOS006228408 |
qgf1p560aw , |
4-01-00-00703 (beilstein handbook reference) |
unii-qgf1p560aw |
FT-0611678 |
chloro-1,1-difluoroethylene |
r-1122 |
2,2-difluoro-1-chloroethene |
freon r 1122 |
R1122 , |
chloro-1,1-difluoroethylene, 2- |
2-chloro-1,1-difluoro-ethene |
hcfc-1122 |
1,1-difluoro-2-chloroethylene |
cf2=chcl |
DTXSID3073898 |
mfcd00042134 |
Q26841345 |
methyl4-(3-thienyl)benzoate |
2-chloro-1,1-difluoroethylene(fc-1122) |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Pathways (1)
Pathway | Proteins | Compounds |
---|---|---|
Halothane Pathway, Pharmacokinetics | 4 | 1 |
Research
Studies (16)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 13 (81.25) | 18.7374 |
1990's | 3 (18.75) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.21
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.21) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (5.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 19 (95.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |